Skip to main content
OpenTrials
Completed

NCT Number: NCT00781664

Cumulative Irritation Test

The purpose of this study is to determine the cumulative irritation potential of the products listed by the Sponsor.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

The Education and Research Foundation, Inc.

Lynchburg, Virginia, 24501, United States

About this study

Healthy, adult volunteers of either sex will be patched daily on his/her back with multiple strengths of AN2718 in 2 different topical dosage forms and an active comparator over the course of 21 consecutive days. Twenty-four hours after each application, the patches will be removed and the site evaluated using a five-point scale for irritation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects must meet all of the following criteria for inclusion in the study.

  • Healthy volunteers of either sex, at least 18 years of age or older.
  • Females must be of non-childbearing potential (i.e., post-menopausal or surgically sterile [bilateral oophorectomy and/or total hysterectomy]). All females must submit to a urine pregnancy test and have a negative result at Day 1 and at the final study visit.
  • Subjects may be of any skin type or race providing their degree of skin pigmentation does not interfere with making readings of skin reactions.
  • Willingness to follow the study procedures and complete the study.
  • Written informed consent obtained.

Exclusion criteria

  • Any skin disease that would in any way confound interpretation of the study results. Atopic dermatitis/eczema, psoriasis will be excluded.
  • Chronic asthma will be excluded.
  • Pregnant or nursing mothers.
  • A history of sensitivity to any component of any of the formulations.
  • Use of chronic medications (such as antihistamines, corticosteroids, analgesics and anti-inflammatories) for one week before and during the study.

Treatment and study plan

AN2718

Other

AN2718 Cream SF Vehicle, Daily for up to 21 days

AN2718

Drug

AN2718 Cream SF, 0.3%, Daily for up to 21 days

sodium lauryl sulfate

Other

Sodium Lauryl Sulfate, 0.5%, Daily for up to 21 days

Other names: SLS

Primary outcomes

  1. Irritation Score (5-point scale)

    Time frame: Daily for 21 days

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

21-Day Cumulative Irritation Test

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Oct 29, 2008
Registry last updated
Apr 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.